Skip to content
Recall Observatory FDA recall evidence

Drug product

Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04

D-0518-2024

May 08, 2024

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 94602
Status
Terminated
Classification
Class II
Quantity
51,006 bottles
Official record key
drug-enforcement:D-0518-2024

Official wording

Reason: Defective container: lack of seal integrity.

Code information: Lot #F305184, F305185, F305186, Exp 7/31/ 2025

Distribution pattern: USA Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective container: lack of seal integrity.